Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,267 public trials 689 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Completed

Study of NG-641 in Combination With Nivolumab in Metastatic or Advanced Epithelial Tumours

NCT05043714

Conditions
Carcinoma, Epithelial Tumor, Metastatic Cancer, +7 more
Locations
  • Providence Medical Foundation Fullerton, California, United States
  • UCLA Department of Medicine Santa Monica, California, United States
  • Moffitt-Advent Health Clinical Research Unit Celebration, Florida, United States
  • University of Cincinnati Cancer Center Cincinnati, Ohio, United States
View Trial Details
Completed

First in Human Study With NG-641, a Tumour Selective Transgene Expressing Adenoviral Vector

NCT04053283

Conditions
Carcinoma, Epithelial Tumor, Infections, +9 more
Locations
  • University of Southern California (USC) - Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Santa Barbara, California, United States
  • Moffitt-Advent Health Clinical Research Unit Celebration, Florida, United States
  • Ochsner Medical Center (OMC) - The Gayle and Tom Benson Cancer Center New Orleans, Louisiana, United States
View Trial Details
Completed

Cytoreductive Prostatectomy Versus Cytoreductive Prostate Irradiation As a Local Treatment Option for Metastatic Prostate Cancer: a Multicentric Feasibility Trial

NCT03655886

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
Locations
  • Antwerp University Hospital Edegem, Antwerp, Belgium
  • AZ Jan Palfijn Ghent, East Flanders, Belgium
  • Leuven University Hospital Leuven, Flemish Brabant, Belgium
  • AZ Maria Middelares Ghent, Belgium
View Trial Details
Completed

Efficacy Assessment of Lenvatinib Associated with Pembrolizumab in Metastatic Endometrial Cancer: a French Multicentric Retrospective Early Access Program-based Study

NCT06599463

Conditions
Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations
  • ICO Paul Papin Angers, France
  • Sainte Catherine - Institut du Cancer Avignon Avignon, France
  • CHU Jean Minjoz Besançon, France
  • ICONE Bezannes, France
View all 24 locations
View Trial Details
Completed

Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer

NCT02492711

Conditions
HER-2 Positive Breast Cancer, Metastatic Neoplasm, Neoplasm Metastasis, +4 more
Locations
  • Ironwood Cancer & Research Center Chandler, Arizona, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Western Regional Medical Center, Inc. Goodyear, Arizona, United States
  • East Valley Hematology And Oncology Burbank, California, United States
View all 167 locations
View Trial Details
Completed

A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors

NCT04761198

Conditions
Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +5 more
Locations
  • Mereo Investigator Site Phoenix, Arizona, United States
  • Mereo Investigator Site Greenbrae, California, United States
  • Mereo Investigator Site Los Angeles, California, United States
  • Mereo Investigator Site Jacksonville, Florida, United States
View all 16 locations
View Trial Details

Related conditions